Association of interferon-based therapy with risk of autoimmune diseases in patients with chronic hepatitis C virus infection: A population-based Taiwanese cohort study
BackgroundInterferon in combination with ribavirin has been the standard of care for chronic hepatitis C virus infection (HCV) for the past few decades. However, its effect on the risk of autoimmune diseases (ADs) among patients with HCV infection remains unclear. We assessed the potential associati...
Main Authors: | Shu-Ming Chou, Hsing-Jung Yeh, Tzu-Min Lin, Yu-Sheng Chang, Hui-Ching Hsu, Yu-Chuan Shen, Tzu-Tung Kuo, Jin-Hua Chen, Shu-Chuan Chen, Chi-Ching Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.992819/full |
Similar Items
-
Proton Pump Inhibitors Increase the Risk of Autoimmune Diseases: A Nationwide Cohort Study
by: Sheng-Hong Lin, et al.
Published: (2021-09-01) -
Serum selenium status in Graves' disease and Hashimoto's thyroiditis in an iodine-sufficient area: A case–control study
by: Zahra Heidari, et al.
Published: (2022-01-01) -
Graves disease is more prevalent than Hashimoto disease in children and adolescents with type 1 diabetes
by: Lu-Ting Wang, et al.
Published: (2023-01-01) -
CORRELATION OF SINGLE NUCLEOTIDE POLYMORPHISM OF THE INTERLEUKIN-27 GENE IN AUTOIMMUNE THYROID DISEASE.
by: Maryam H. I, et al.
Published: (2024-12-01) -
A case of simultaneous occurrence of Graves′ disease and Hashimoto′s thyroiditis
by: Anirban Majumder, et al.
Published: (2012-01-01)